Altre lingue Firebrick Pharma Limited

Azioni

FRE

AU0000197352

Mercato chiuso - Australian S.E. Altri mercati azionari 08:10:41 03/07/2024			Variaz. 5gg	Var. 1 gen.
0,051 ^AUD	-1,92%		-1,92%	+2,00%

13/06	Firebrick Pharma lancia Nasodine Spray Nasale a Singapore	MT
23/05	Firebrick Pharma ottiene il brevetto della composizione Nasodine in Sudafrica	MT

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Firebrick Pharma Launches Nasodine Nasal Spray in Singapore	13/06
Firebrick Pharma Obtains Nasodine Composition Patent in South Africa	23/05
Firebrick Pharma Raises AU$800,000 via Placement	17/05
Firebrick Pharma Appoints Auditor	06/05
Firebrick Pharma's Nasodine Nasal Spray Enters US Market	17/04
Firebrick Pharma Phase 2 Covid-19 Trial Published in Laryngoscope Journal	03/04
Firebrick Pharma Gets Coverage Extension of COVID-19 Patent in US	04/03
Firebrick Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
62,732,537 Ordinary Shares of Firebrick Pharma Limited are subject to a Lock-Up Agreement Ending on 28-JAN-2024.	28/01
Firebrick Pharma to Release Shares from Escrow; Shares Rise 4%	12/01
Firebrick Pharma Withdraws Appeal Against Regulator's Decision Over Nasodine Nasal Spray	27/12
Firebrick Pharma's Nasodine Nasal Spray COVID-19 Patent Granted in South Africa	29/11
Firebrick Pharma Receives AU$1.8 Million R&D Tax Rebate	31/10/23
Firebrick Says Independent Probe Into Nasodine Trial Results Did Not Find Errors	04/10/23
Firebrick Pharma's Cold Medication Fails Phase III Trial	13/09/23
Firebrick Pharma Limited Announces That Trial Statisticians Have Completed Their Efficacy Analysis of the Headline Results in the Phase 3 Trial of Nasodine® Nasal Spray as A Treatment for the Common Cold	13/09/23
Firebrick Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2023	29/08/23
Firebrick Pharma Completes Enrollment for Cold Treatment Trial; Shares Soar 17%	09/08/23
Firebrick Update on Administrative Appeals Tribunal Process	20/07/23
Firebrick Pharma's Nasal Spray Patent Allowed in Canada	09/05/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Firebrick Pharma Limited

Azioni

FRE

AU0000197352

Altre lingue

Filtri